Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Y Graham

Showing results (431-440 of 481) with videos related to

Pageof 49
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 24, 2017
Gastric Cancer as Preventable DiseaseMassimo Rugge, Robert M Genta, Francesco Di Mario, et al.
The New England Journal of Medicine|December 14, 2011
Norovirus vaccine against experimental human Norwalk Virus illnessRobert L Atmar, David I Bernstein, Clayton D Harro, et al.
The American Journal of Gastroenterology|March 15, 2018
Acute pancreatitis with long-term celecoxib vs. ibuprofen or naproxen: data from the PRECISION trialNeville D Yeomans, David Y Graham, Qiuqing Wang, et al.
Gut Microbes|January 22, 2019
<i>Bacteroides ovatus</i> ATCC 8483 monotherapy is superior to traditional fecal transplant and multi-strain bacteriotherapy in a murine colitis modelFaith D Ihekweazu, Tatiana Y Fofanova, Karen Queliza, et al.
Clinical and Vaccine Immunology : CVI|October 5, 2012
Antibody responses to norovirus genogroup GI.1 and GII.4 proteases in volunteers administered Norwalk virusNadim J Ajami, Meagan A Barry, Berenice Carrillo, et al.
Gut|April 12, 2012
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus ReportPeter Malfertheiner, Francis Megraud, Colm A O'Morain, et al.
Gut|February 21, 2024
RE.GA.IN.: the Real-world Gastritis Initiative-updating the updatesMassimo Rugge, Robert M Genta, Peter Malfertheiner, et al.
Frontiers in Immunology|February 2, 2023
Fourteen-day vonoprazan and low- or high-dose amoxicillin dual therapy for eradicating <i>Helicobacter pylori</i> infection: A prospective, open-labeled, randomized non-inferiority clinical studyYi Hu, Xin Xu, Xiao-Shun Liu, et al.
International Journal of Molecular Epidemiology and Genetics|May 24, 2017
Expression of pattern recognition receptor genes and mortality in patients with colorectal adenocarcinomaKathryn E Royse, Liang Chen, David H Berger, et al.
Science (New York, N.Y.)|January 24, 2009
The peopling of the Pacific from a bacterial perspectiveYoshan Moodley, Bodo Linz, Yoshio Yamaoka, et al.
Pageof 49

Showing results (431-440 of 481) with videos related to

Sort By:
Pageof 49
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 24, 2017
Gastric Cancer as Preventable DiseaseMassimo Rugge, Robert M Genta, Francesco Di Mario, et al.
The New England Journal of Medicine|December 14, 2011
Norovirus vaccine against experimental human Norwalk Virus illnessRobert L Atmar, David I Bernstein, Clayton D Harro, et al.
The American Journal of Gastroenterology|March 15, 2018
Acute pancreatitis with long-term celecoxib vs. ibuprofen or naproxen: data from the PRECISION trialNeville D Yeomans, David Y Graham, Qiuqing Wang, et al.
Gut Microbes|January 22, 2019
<i>Bacteroides ovatus</i> ATCC 8483 monotherapy is superior to traditional fecal transplant and multi-strain bacteriotherapy in a murine colitis modelFaith D Ihekweazu, Tatiana Y Fofanova, Karen Queliza, et al.
Clinical and Vaccine Immunology : CVI|October 5, 2012
Antibody responses to norovirus genogroup GI.1 and GII.4 proteases in volunteers administered Norwalk virusNadim J Ajami, Meagan A Barry, Berenice Carrillo, et al.
Gut|April 12, 2012
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus ReportPeter Malfertheiner, Francis Megraud, Colm A O'Morain, et al.
Gut|February 21, 2024
RE.GA.IN.: the Real-world Gastritis Initiative-updating the updatesMassimo Rugge, Robert M Genta, Peter Malfertheiner, et al.
Frontiers in Immunology|February 2, 2023
Fourteen-day vonoprazan and low- or high-dose amoxicillin dual therapy for eradicating <i>Helicobacter pylori</i> infection: A prospective, open-labeled, randomized non-inferiority clinical studyYi Hu, Xin Xu, Xiao-Shun Liu, et al.
International Journal of Molecular Epidemiology and Genetics|May 24, 2017
Expression of pattern recognition receptor genes and mortality in patients with colorectal adenocarcinomaKathryn E Royse, Liang Chen, David H Berger, et al.
Science (New York, N.Y.)|January 24, 2009
The peopling of the Pacific from a bacterial perspectiveYoshan Moodley, Bodo Linz, Yoshio Yamaoka, et al.
Pageof 49